Compile Data Set for Download or QSAR
Report error Found 66 Enz. Inhib. hit(s) with all data for entry = 10836
TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572517(5-Bromo-2-(N-azetidinylcarbamoyl)-3-pyridyl 3-deox...)
Affinity DataKd:  6nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572516(5-Bromo-2-(N-azetidinylcarbamoyl)-3-pyridyl 3-[4-(...)
Affinity DataKd:  7nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572496(2-(N-azetidinyl-carbonyl)-5-chlorophenyl 3-deoxy-3...)
Affinity DataKd:  7nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572518(5-Bromo-2-(N-azetidinylcarbamoyl)-3-pyridyl 3-[4-(...)
Affinity DataKd:  8nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572462(4-Chloro-N,N- dimethyl-benzamide-2- yl 3-deoxy-3...)
Affinity DataKd:  8nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572521(5-Chloro-2-(N-azetidinylcarbamoyl)-3-pyridyl 3-[4-...)
Affinity DataKd:  10nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572524(5-Chloro-2-(N-azetidinylcarbamoyl)-3-pyridyl 3-[4-...)
Affinity DataKd:  11nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572468(5-Chloro-2-cyanopyridin-3-yl 3-deoxy-3-[4-(3,5-dif...)
Affinity DataKd:  12nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572525(2-(N-azetidinyl-carbonyl)-5-chlorophenyl 3-deoxy-3...)
Affinity DataKd:  12nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572469(5-Chloro-2-cyanopyridin-3-yl 3-deoxy-3-[4-(3-fluor...)
Affinity DataKd:  14nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572463(4-Chloro-N,N-dimethyl-benzamide-2-yl 3-[4-(4-chlor...)
Affinity DataKd:  14nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572495(2-(N-azetidinyl-carbonyl)-5-chlorophenyl 3-[4-(4-c...)
Affinity DataKd:  15nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572519(2-(N-azetidinyl-carbonyl)-5-bromophenyl 3-deoxy-3-...)
Affinity DataKd:  16nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572507(5-Chloro-2-(N-azetidinylcarbamoyl)-3-pyridyl 3-[4-...)
Affinity DataKd:  16nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572523(5-Chloro-2-(N-azetidinylcarbamoyl)-3-pyridyl 3-[4-...)
Affinity DataKd:  17nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572520(2-(N-azetidinyl-carbonyl)-5-bromophenyl 3-deoxy-3-...)
Affinity DataKd:  18nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572474(5-Bromopyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluorop...)
Affinity DataKd:  20nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572508(5-Chloro-2-(N-azetidinylcarbamoyl)-3-pyridyl 3-[4-...)
Affinity DataKd:  21nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572489(5-Chloropyridin-3-yl 3-[4-(4-chloro-3,5-difluoroph...)
Affinity DataKd:  21nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572522(5-Chloro-2-(N-azetidinylcarbamoyl)-3-pyridyl 3-deo...)
Affinity DataKd:  21nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572505(5-Bromo-2-cyanopyridin-3-yl 3-[4-(4-chloro-3,5-dif...)
Affinity DataKd:  23nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572480(5-Chloro-2-(pyridin-2-yl)pyridin-3-yl 3-deoxy-3-[4...)
Affinity DataKd:  24nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572461(5-Bromopyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluorop...)
Affinity DataKd:  25nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572491(5-Chloropyridin-3-yl 3-deoxy-3-[4-(3-fluoro-4-meth...)
Affinity DataKd:  26nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572511(2-Cyano-5-ethynylpyridin-3-yl 3-[4-(4-chloro-3,5-d...)
Affinity DataKd:  28nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572479(5-Chloro-2-(pyrimidin-5-yl)pyridin-3-yl 3-deoxy-3-...)
Affinity DataKd:  28nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572497(5-Chloropyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluoro...)
Affinity DataKd:  29nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572503(5-Chloro-2-cyanopyridin-3-yl 3-[4-(4-chloro-3-fluo...)
Affinity DataKd:  31nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572488(5-Chloropyridin-3-yl 3-[4-(4-chloro-3,5-difluoroph...)
Affinity DataKd:  31nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572466(5-Chloro-2-{N-(2-oxa)- 6- azaspiro[3.3]heptanyl}...)
Affinity DataKd:  33nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572502(5-Chloro-2-cyanopyridin-3-yl 3-[4-(4-chloro-3,5-di...)
Affinity DataKd:  34nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572501(5-Chloro-2-cyanopyridin-3-yl 3-deoxy-3-[4-(3,4,5-t...)
Affinity DataKd:  35nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572512(2-Cyano-5-ethynylpyridin-3-yl 3-deoxy-3-[4-(3,5-di...)
Affinity DataKd:  35nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572509(5-Ethynylpyridin-3-yl 3-[4-(4-chloro-3,5-difluorop...)
Affinity DataKd:  35nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572483(5-Chloro-2-(1,2,3,6-tetrahydropyridin-4-yl)pyridin...)
Affinity DataKd:  36nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572506(5-Bromo-2-cyanopyridin-3-yl 3-[4-(4-chloro-3-fluor...)
Affinity DataKd:  37nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572478(5-Chloro-6-cyano-2-{N-(2-oxa)-6-azaspiro[3.3]hepta...)
Affinity DataKd:  37nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572498(5-Chloropyridin-3-yl 3-deoxy-3-[4-(6-fluoro-5-meth...)
Affinity DataKd:  39nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572492(5-Chloropyridin-3-yl 3-[4-(4-chloro-3-fluorophenyl...)
Affinity DataKd:  42nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572490(5-Chloropyridin-3-yl 3-deoxy-3-[4-(3-fluoro-4-meth...)
Affinity DataKd:  45nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572467(5-Chloro-2-{N-(2-oxa)-6-azaspiro[3.3]heptanyl}-pyr...)
Affinity DataKd:  49nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572504(2-Cyano-5-methylpyridin-3-yl 3-[4-(4-chloro-3,5-di...)
Affinity DataKd:  50nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572470(5-Chloro-2-cyanophenyl 3-deoxy-3-[4-(3,5-difluoro-...)
Affinity DataKd:  50nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572481(5-Chloro-2-(pyridin-3-yl)pyridin-3-yl 3-deoxy-3-[4...)
Affinity DataKd:  55nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572482(5-Chloro-2-(pyridin-4-yl)pyridin-3-yl 3-deoxy-3-[4...)
Affinity DataKd:  56nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572485(5-Chloro-2-(oxazol-2-yl)pyridin-3-yl 3-deoxy-3-[4-...)
Affinity DataKd:  56nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572476(3,4-Dichlorophenyl 3-[4-(4-chloro-3,5-difluorophen...)
Affinity DataKd:  58nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572471(5-Chloro-2- cyanopyridin-3-yl 3- deoxy-2-O-ethyl-...)
Affinity DataKd:  59nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572477(5-Chloro-6-cyano-2-{N-(2-oxa)-6-azaspiro[3.3]hepta...)
Affinity DataKd:  60nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM572493(5-Chloropyridin-3-yl 3-[4-(4-chloro-3-fluorophenyl...)
Affinity DataKd:  62nMAssay Description:The affinity of Example 1-71 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

Displayed 1 to 50 (of 66 total ) | Next | Last >>
Jump to: